Felix Mhlanga

Biographic Data

ID7727309
NAMEFelix Mhlanga
GIVEN NAMESFelix
FAMILY NAMEMhlanga
SIGNATUREMHLANGA F
AFFILIATIONSUniversity of Zimbabwe
ORCID0000-0003-3294-3567
VERIFIEDYes
TOTAL WORKS9
TOTAL CITATIONS0
WORKS AS AUTHOR9
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2024
H-INDEX0

  • “We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine.” Factors influencing the choice of safer conception methods and experiences with its use

    Open AccessJoelle Brown, Joelle M Brown et al.ARTICLEBMC Public Health2024

    The differences in method preferences and experiences voiced by participants in this study and in other studies from the region point to the importance of having a variety of safer conception options in the service delivery package and addressing concerns about paternity, intimacy, and method-related attributes to enable HIV sero-discordant couples to safely achieve their reproductive goals

  • Preventing HIV and achieving pregnancy among HIV sero-different couples

    Open AccessJoelle Brown, Serah Gitome et al.ARTICLEPLOS Global Public Health2023

    Safer conception services are needed to minimize HIV transmission among HIV sero-different couples desiring pregnancy. Few studies have evaluated the choices couples make when offered multiple safer conception methods or real-world method acceptability and effectiveness. We piloted a comprehensive safer conception program ( Clintrials . gov identifier: NCT03049176) for HIV sero-different couples planning pregnancy in Zimbabwe to measure feasibili…

  • Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

    Open AccessMarla Husnik, Elizabeth R Brown et al.ARTICLEAIDS and Behavior2021

  • Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

    Open AccessAshley Mayo, Erica N Browne et al.ARTICLEAIDS and Behavior2021

    We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…

  • The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

    Open AccessMarie C D Stoner, Elizabeth R Brown et al.ARTICLEAIDS and Behavior2021

  • Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa

    Felix Mhlanga, Mhlanga Mhlanga et al.ARTICLEInternational Perspectives on…2019

    CONTEXT: The copper IUD is safe and effective, but underutilized in Sub-Saharan Africa, in part because of a lack of trained providers. The World Health Organization recommends training mid-level providers-including nurses and midwives-to insert IUDs; however, the safety of such task shifting has not been evaluated in Sub-Saharan Africa. METHODS: Data were drawn from baseline surveys and study charts of 535 sexually active women aged 18-45 who us…

  • Complex decisions

    Margaret R Caplan, Raphael J Landovitz et al.ARTICLEAIDS Care2019

    Contraceptive adherence during acute and recent HIV-1 infection is important to maternal and child health given the elevated risk of vertical HIV-1 transmission and additional complications of pregnancy. Injectable contraception (IC) is the most common non-barrier modern contraception method used in sub-Saharan Africa (SSA). Adherence to IC after HIV-1 seroconversion is not well understood. We examined factors associated with IC discontinuation a…

  • Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    Jared M Baeten, Thesla Palanee‐phillip et al.ARTICLENew England Journal of Medicine2016

    BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…

  • The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe

    Open AccessMarshall Munjoma, Marshall W Munjoma et al.ARTICLEBMC Public Health2010

    The incidence of HIV was high during the first nine months after childbirth. Time of seroconversion, age and educational level of seroconverter are important factors that must be considered when designing HIV intervention strategies